Patient info Open main menu

Crinone Progesterone vaginal gel 8% – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
8% (80 mg/gram)
Contains active substance:
Similar medicines:

Patient leaflet - Crinone Progesterone vaginal gel 8%

1. What Crinone is and what it is used for

The full name of your medicine is Crinone 8% w/w vaginal gel. In this leaflet the shorter name Crinone is used. Crinone contains a hormone called progesterone. When the gel is inserted into your vagina, the progesterone is slowly released into your bloodstream throughout the day.

Crinone is used to give you extra progesterone in the treatment of infertility due to incorrect levels of progesterone during the menstrual cycle or when you are having an assisted fertility procedure. This is to help you get pregnant. You may also be asked to continue using Crinone to support your new pregnancy.

2. What you need to know before you use Crinone

Do not use Crinone

  • if you are allergic to the active substance or any of the

    other ingredients of this medicine (listed in section 6). • if you have unexplained vaginal bleeding • if you have porphyria (an inability to break down

    certain substances (porphyrins) in your blood that is passed down in families)

  • if you have or think you might have cancer in your

    breasts or genital organs

  • if you have ever had a blood clot due to swollen

    veins (thrombophlebitis), a blocked blood vessel (thromboembolic disorder) or a stroke

  • if you are pregnant but your baby has died inside of

    you (missed abortion).

Do not use Crinone if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before using this medicine.

Warnings and precautions

Talk to your doctor or pharmacist before using Crinone if any of the following apply to you. They may want to monitor you more closely during treatment: Package Leaflet: Information for the user

Crinone® 8% w/w

Vaginal Gel

progesterone

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or

    pharmacist or nurse.

  • This medicine has been prescribed for you only.

    Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

  • If you get any side effects talk to your doctor or

    pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

    • if you have liver or kidney problems
    • if you have heart problems or diabetes
    • if you have asthma
    • if you have epilepsy or often get migraines
    • if you have ever had depression.

Tell your doctor if you get any unexpected bleeding so that they can investigate the cause of this.

Children and adolescents

Crinone is not for use in children or adolescents.

Tests and check ups

Check ups are required before you use this medicine and every so often when you are using it. In particular:

  • Before using this medicine, your doctor will need to do

    a smear test and check your breasts and pelvic area.

  • During your treatment, your doctor will check for any

    problems with your womb such as the lining getting thicker (endometrial hyperplasia). They will also check for any signs of blood clots in your blood vessels.

Other medicines and Crinone

Do not use Crinone at the same time as any other medicines that are inserted into your vagina.

Tell your doctor or pharmacist if you are taking, or have recently taken any other medicines, including medicines obtained without a prescription.

Pregnancy and breast-feeding

  • Crinone is not normally used during pregnancy.

    However, if you used Crinone to help you get pregnant, you may be asked to continue using it to support your new pregnancy.

  • The use of Crinone during breast-feeding is not

    recommended.

Driving and using machines

Crinone has no influence on the ability to drive and use machines.

Crinone contains sorbic acid

Crinone contains sorbic acid. This may cause local skin reactions such as contact dermatitis. These skin reactions mightalsooccuronyourpartner’spenisifyouhavesexwhile using Crinone. This may be prevented by using condoms.

3. How to use Crinone

Always use Crinone exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Insert the contents of one applicator of Crinone into your vagina each day, starting after your doctor tells you that you have ovulated, or on the 18th-21st day of your menstrual cycle. (The first day of your menstrual cycle is the day your period starts.)

When used during in-vitro fertilisation, from the day of the embryo transfer, insert the contents of one applicator of Crinone into your vagina each day, preferably in the morning. Once tests confirm that you are pregnant, you may be asked to keep using Crinone to support your new pregnancy – for a total of 30 days.

The applicator is designed in such a way that an exact amount of gel (1.125 g, containing 90 mg progesterone) is delivered. It is expected that a small amount of gel will be left in the applicator. This can be thrown away as you will have received all of the medicine that you need.

How to use

This medicine is only for use in your vagina using the pre-filled applicator supplied in the pack.

Before using the applicator, please read all of the instructions below.

What your applicator looks like

  1. 1. air tank
  2. 2. flat part of the thick end
  3. 3. thick end
  4. 4. thin end
  5. 5. cap
Info-Table - Version 03
IDENTIFICATION OF THE COMPONENT
MUP-001748
Local brand:CRINONE
Strength(s):8%
TECHNICAL DATA
Packaging site:Catalent Nottingham UK
Technical layout ref:297x210mm_V05
BARCODE
Alpha numeric content:Placeholder
Spotmark:No
Spotmark value:No
TRACEABILITY (VERSIONS)

MUP-001748 TW4751896 Getting your applicator ready

Grip the applicator by the thick end between your thumb and index finger. Face the thin end of the applicator down to the ground and shake the applicator down to move all the gel inside to the thin end.

Opening your applicator

Grip the applicator by the flat part of the thick end. Twist off and remove the cap from the opposite thin end. To stop the gel from flowing out before use, do not press the air tank at the thick end at this stage.

Inserting your applicator

Lean back or lie down with your knees bent and spread apart. Carefully insert the applicator well into your vagina, until your hand touches your body.

Press the air tank at the thick end of the applicator firmly to deliver the gel from the applicator into your vagina.

After using your applicator

Throw away the applicator, including the small amount of gel that is left inside. Use each applicator only once.

Crinone gel can stay in your vagina for several days. You may get a beige to brownish clumpy or cloudy white discharge during this time. This is nothing to worry about.

If you use more Crinone than you should

You are unlikely to use too much of this medicine as each applicator contains the right amount.

If you forget to use Crinone

Do not use a double dose to make up for a forgotten dose. If you forget to use Crinone on one day, please continue as usual with a single dose on the following day. If you have any further questions on the use of this medicine ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Allergic reactions

If you get an allergic reaction stop taking Crinone and see a doctor straight away. You may get for example an itchy skin rash. It is not known how likely this side effect is.

Other side effects

Common (may affect up to 1 in 10 people): • breast tenderness.

Frequency not known (cannot be estimated from the available data):

  • bleeding between periods (spotting)
  • irritation or other mild reactions in or around your vagina.

Please note

Crinone gel can stay in your vagina for several days. You may get a beige to brownish clumpy or cloudy white discharge during this time. This discharge can cause irritation, pain or swelling of the vagina but this is nothing to worry about.

Reporting side effects

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www. mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Crinone

  • Keep this medicine out of the sight and reach of children.

    • Do not use this medicine after the expiry date which is stated on the cartons and the wrapper after ‘EXP’. The expiry date refers to the last day of that month. • Do not store above 25°C.
    • Use each applicator only once. Any gel left in the applicator must be thrown away.
    • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and further information

What Crinone contains

  • The active substance is progesterone. From each applicator 1.125 g vaginal gel, containing 90 mg progesterone, is delivered into the vagina. • The other ingredients are sorbic acid, glycerine, light liquid paraffin, hydrogenated palm oil glycerides, carbomer 974P, polycarbophil, sodium hydroxide and purified water.

What Crinone looks like and contents of the pack

Crinone is a smooth white to off-white gel. It is filled in single-use, one-piece, white polyethylene vaginal applicators with twist-off caps, each sealed in a paper /aluminium / ionomer resin foil wrapper.

Crinone is supplied in packs of 6 or 15 single-use applicators. Not all pack sizes may be marketed.

Marketing Authorisation Holder

Merck Serono Ltd

5 New Square

Bedfont Lakes Business Park

Feltham

Middlesex

TW14 8HA

United Kingdom

Manufacturer

Central Pharma (Contract Packaging) Ltd

Caxton Road

Bedford, MK41 OXZ

United Kingdom

or

Catalent France Beinheim

74, rue Principale

Beinheim, 67930

France

This leaflet was last revised in January 2025 Info-Table - Version 03

IDENTIFICATION OF THE COMPONENT

Local brand: CRINONE

Strength(s): 8%

TECHNICAL DATA

Packaging site: Catalent Nottingham UK

Technical layout ref: 297x210mm_V05

BARCODE

Alpha numeric content: Placeholder

Spotmark: No

Spotmark value: No

TRACEABILITY (VERSIONS)

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 11648/0261

Last revision stated in the text: January 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Crinone Progesterone vaginal gel 8%

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Progesterone
Strength 8% (80 mg/gram)
Pharmaceutical form Vaginal gel
How is it taken Vaginal
Excipients Glycerin, Light Liquid Paraffin, Hydrogenated Palm Oil Glyceride, Carbopol 974P, Sorbic acid, Polycarbophil, Sodium hydroxide, Purified water.
Pack sizes 15 unit dose
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months.
Storage Store below 25°C.
Drug group (ATC) Sex hormones
  1. G Genito urinary system and sex hormones
    1. G03 Sex hormones and modulators of the genital system
      1. G03D Progestogen sex hormones and modulators of the genital system
        1. G03DA Pregnen (4) derivatives, progestogens
          1. G03DA04 progesterone
Marketing authorisation PL 11648/0261 (first authorised 9 June 1995)
Marketing authorisation holder Merck Serono Limited
Codes GTIN 5018431470151 · BNF 06040102

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.